Legend Biotech (LEGN) Finished Goods (2022 - 2025)

Legend Biotech has reported Finished Goods for 4 years, with the latest figure at $2.8 million in Q1 2025.

• For the quarter ending Q1 2025, Finished Goods rose 67.6% year-over-year to $2.8 million; the trailing twelve-month figure through Mar 2025 stood at $2.8 million (up 67.6% YoY), and the FY2024 full-year result was $2.0 million, down 38.9% from the prior year.
• Finished Goods for Q1 2025 stood at $2.8 million, up from $2.0 million in the prior quarter.
• The five-year high for Finished Goods was $4.0 million in Q3 2023, with the low at $425000.0 in Q3 2024.
• Historically, Finished Goods has averaged $2.4 million across 4 years, with a median of $2.7 million in 2022.
• Annual changes were most pronounced in 2024 — Finished Goods plunged 89.35% — and 2025, when it soared 67.6%.
• Legend Biotech's Finished Goods stood at $2.7 million in 2022, then grew by 22.92% to $3.3 million in 2023, then plunged by 38.9% to $2.0 million in 2024, then jumped by 40.57% to $2.8 million in 2025.
• The last three Finished Goods figures came in at $2.8 million (Q1 2025), $2.0 million (Q4 2024), and $425000.0 (Q3 2024), per Business Quant data.